Incomplete type of intestinal metaplasia has the highest risk to progress to gastric cancer: results of the Spanish follow-up multicenter study.

González CA, Sanz-Anquela JM, Companioni O, Bonet C, Berdasco M, López C, Mendoza J, Martín-Arranz MD, Rey E, Poves E, Espinosa L, Barrio J, Torres MÁ, Cuatrecasas M, Elizalde I, Bujanda L, Garmendia M, Ferrández Á, Muñoz G, Andreu V, Paules MJ, Lario S, Ramírez MJ, Study group, Gisbert JP.

Journal Of Gastroenterology And Hepatology. 2016; 31: 953-958. FI: 3,452 (Q2).

Impact of age- and gender-specific cut-off values for the fecal immunochemical test for hemoglobin in colorectal cancer screening.

Alvarez-Urturi C, Andreu M, Hernandez C, Perez-Riquelme F, Carballo F, Ono A, Cruzado J, Cubiella J, Hernandez V, Mao CG, Perez E, Salas D, Andrés M, Bujanda L, Portillo I, Sarasqueta C, Quintero E, Morillas JD, Lanas A, Sostres C, Augé JM, Castells A, Bessa X, COLONPREV study investigators.

Digestive And Liver Disease. 2016; 48: 542-551. FI: 3,061 (Q2).

Prevalence of severe esophagitis in Spain. Results of the PRESS study (Prevalence and Risk factors for Esophagitis in Spain: A cross-sectional study).

Piqué N, Ponce M, Garrigues V, Rodrigo L, Calvo F, de Argila CM, Borda F, Naranjo A, Alcedo J, José Soria M, Rey E, Bujanda L, Gisbert JP, Suarez D, Calvet X, Ponce J, PRESS Study Group.

United European Gastroenterology Journal. 2016; 4: 229-235. FI: 3,673 (Q2).

Immunotherapy in colorectal cancer: What have we learned so far?

Sanchez-Castañón M, Er TK, Bujanda L, Herreros-Villanueva M.

Clinica Chimica Acta. 2016; 460: 78-87. FI: 2,873 (Q2).

Colorectal cancer health services research study protocol: The CCR-CARESS observational prospective cohort project.

Quintana JM, Gonzalez N, Anton-Ladislao A, Redondo M, Bare M, Fernandez de Larrea N, Briones E, Escobar A, Sarasqueta C, Garcia-Gutierrez S, Aguirre U, REDISSEC-CARESS/CCR group.

Bmc Cancer. 2016; 16: 435-435. FI: 3,288 (Q2).

LACC1 polymorphisms in inflammatory bowel disease and juvenile idiopathic arthritis.

Assadi G, Saleh R, Hadizadeh F, Vesterlund L, Bonfiglio F, Halfvarson J, Torkvist L, Eriksson AS, Harris HE, Sundberg E, D'Amato M.

Genes And Immunity. 2016; 17: 261-264. FI: 2,524 (Q2).

Influence of Dopaminergic System Genetic Variation and Lifestyle Factors on Excessive Alcohol Consumption.

Celorrio D, Muñoz X, Amiano P, Dorronsoro M, Bujanda L, Sánchez MJ, Molina-Montes E, Navarro C, Chirlaque MD, MaríaHuerta J, Ardanaz E, Barricarte A, Rodriguez L, Duell EJ, Hijona E, Herreros-Villanueva M, Sala N, Alfonso-Sánchez MA, de Pancorbo MM.

Alcohol And Alcoholism. 2016; 51: 258-267. FI: 2,757 (Q2).

Report of the Asociación Española de Coloproctología President.

Enríquez-Navascues JM, Espín-Basany E, Jiménez-Escobar F.

Colorectal Disease. 2016; 18: 440-440. FI: 2,689 (Q2).

Overexpression of MIRNA-506 in human cholangiocytes causes primary biliary cholangitis-like features including mitochondrial dysfunction and increased sensitivity to apoptosis.

Erice O, Munoz-Garrido P, Vaquero J, Perugorria MJ, Fernandez-Barrena MG, Saez E, Arbelaiz A, Santos-Laso A, Jimenez-Aguero R, Fernandez-Irigoyen J, Santamaria E, Torrano V, Carracedo A, Marzioni M, Prieto J, Beuers U, Elferink RO, LaRusso NF, Bujanda L, Marin JJG, Banales JM.

Journal Of Hepatology. 2016; 64: 639-640. FI: 12,486 (Q1).

SOX17 regulates cholangiocyte differentiation and acts as a tumour suppressor in cholangiocarcinoma.

Merino-Azpitarte M, Lozano E, Perugorria MJ, Erice O, Santos-Laso A, Jimenez-Aguero R, LaCasta A, Jalan-Sakrikar N, Huebert RC, Thelen KM, Gradilone S, Aransay AM, Lavin JL, Fernandez-Barrena MG, Marzioni M, Gores GJ, Bujanda L, Marin JJ, Banales JM.

Journal Of Hepatology. 2016; 64: 569-570. FI: 12,486 (Q1).

Potential renoprotective effects of piceatannol in ameliorating the early-stage nephropathy associated with obesity in obese Zucker rats.

Llarena M, Andrade F, Hasnaoui M, Portillo MP, Perez-Matute P, Arbones-Mainar JM, Hijona E, Villanueva-Millan, MJ, Aguirre L, Carpene C, Aldamiz-Echevarria L.

Journal Of Physiology And Biochemistry. 2016; 72: 555-566. FI: 2,444 (Q2).

Limited beneficial effects of piceatannol supplementation on obesity complications in the obese Zucker rat: gut microbiota, metabolic, endocrine, and cardiac aspects.

Hijona E, Aguirre L, Perez-Matute P, Villanueva-Millan MJ, Mosqueda-Solis A, Hasnaoui M, Nepveu F, Senard JM, Bujanda L, Aldamiz-Echevarria, L., Llarena, M., Andrade, F., Perio, P., Leboulanger, F., Hijona, L., Arbones-Mainar JM, Portillo MP, Carpene C.

Journal Of Physiology And Biochemistry. 2016; 72: 567-582. FI: 2,444 (Q2).

The common prosteatotic PNPLA3 (ADIPONUTRIN) P.I148M variant might protect against gallstone disease.

Krawczyk, M, Jimenez-Aguero R, Perugorria MJ, Gallego L, Bujanda L, Lammert F, Banales JM.

Journal Of Hepatology. 2016; 64: 489-490. FI: 12,486 (Q1).

Targeting of MIR-518D Reduces Chemoresistance in Hepatocellular Carcinoma Cell Lines.

Ramos DF, Tussy PF, Perugorria MJ, Banales JM, Briz O, Herraez E, Marin JJG, Mato JM, Chantar MLM.

Journal Of Hepatology. 2016; 64: 561-561. FI: 12,486 (Q1).